Gene Symbol | Gene ID | Gene Info |
---|---|---|
Dlx5
|
ENSMUSG00000029755.9 | distal-less homeobox 5 |
Dlx4
|
ENSMUSG00000020871.7 | distal-less homeobox 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_95148449_95149157 | Dlx4 | 2540 | 0.186172 | 0.52 | 2.2e-05 | Click! |
chr11_95149747_95151109 | Dlx4 | 4165 | 0.147867 | 0.48 | 8.9e-05 | Click! |
chr11_95148012_95148247 | Dlx4 | 1866 | 0.231833 | 0.37 | 4.1e-03 | Click! |
chr11_95146380_95146531 | Dlx4 | 192 | 0.891188 | 0.30 | 1.9e-02 | Click! |
chr11_95145006_95146328 | Dlx4 | 134 | 0.859461 | 0.19 | 1.5e-01 | Click! |
chr6_6880959_6882181 | Dlx5 | 498 | 0.707332 | 0.64 | 3.7e-08 | Click! |
chr6_6878154_6880927 | Dlx5 | 2528 | 0.187666 | 0.64 | 3.9e-08 | Click! |
chr6_6876721_6877127 | Dlx5 | 5144 | 0.133967 | 0.47 | 1.8e-04 | Click! |
chr6_6877373_6877738 | Dlx5 | 4513 | 0.140002 | 0.38 | 2.5e-03 | Click! |
chr6_6884835_6885412 | Dlx5 | 3038 | 0.171521 | 0.15 | 2.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_19215607_19218714 | 17.78 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr4_97582473_97584218 | 15.18 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1251 |
0.53 |
chrX_133682515_133683917 | 14.85 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr7_92234907_92236280 | 13.47 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr17_51760240_51761547 | 13.38 |
C230085N15Rik |
RIKEN cDNA C230085N15 gene |
728 |
0.54 |
chr9_41585694_41587243 | 13.20 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr9_35424475_35426234 | 11.89 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
1766 |
0.31 |
chr2_6881874_6882908 | 10.64 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr2_140668225_140669392 | 10.57 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
2592 |
0.43 |
chr10_125967796_125968797 | 10.48 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2043 |
0.45 |
chr9_41582824_41584205 | 10.47 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr3_148984296_148985724 | 10.32 |
Gm43573 |
predicted gene 43573 |
4142 |
0.2 |
chr12_89815214_89815490 | 10.23 |
Nrxn3 |
neurexin III |
2869 |
0.41 |
chr19_60015391_60016209 | 10.14 |
Csf1r-ps |
colony stimulating factor 1 receptor (granulocyte), pseudogene |
63632 |
0.1 |
chr5_13125231_13126281 | 10.04 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
163 |
0.95 |
chr2_18042311_18043883 | 9.87 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr12_52700044_52701597 | 9.78 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr14_28514085_28515337 | 9.68 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
3260 |
0.25 |
chr2_181763361_181764530 | 9.57 |
Myt1 |
myelin transcription factor 1 |
613 |
0.66 |
chr12_65428156_65429051 | 9.48 |
Gm26015 |
predicted gene, 26015 |
22633 |
0.22 |
chr16_63863108_63864179 | 9.40 |
Epha3 |
Eph receptor A3 |
230 |
0.96 |
chr1_77505286_77506951 | 9.33 |
Epha4 |
Eph receptor A4 |
8961 |
0.18 |
chr7_137318563_137320070 | 9.10 |
Ebf3 |
early B cell factor 3 |
4871 |
0.21 |
chr1_177444257_177446079 | 9.10 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
230 |
0.9 |
chr12_107990188_107992301 | 9.08 |
Bcl11b |
B cell leukemia/lymphoma 11B |
12170 |
0.28 |
chr17_11664263_11665109 | 9.04 |
Gm10513 |
predicted gene 10513 |
67659 |
0.13 |
chr1_168426195_168428871 | 9.04 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr2_57613916_57615034 | 9.00 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chr13_15466077_15468087 | 8.98 |
Gli3 |
GLI-Kruppel family member GLI3 |
3102 |
0.22 |
chr6_96113911_96115198 | 8.80 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chr13_8202516_8203999 | 8.80 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
335 |
0.87 |
chr2_77701567_77703605 | 8.68 |
Zfp385b |
zinc finger protein 385B |
686 |
0.8 |
chr3_86545154_86545526 | 8.47 |
Lrba |
LPS-responsive beige-like anchor |
1415 |
0.43 |
chrX_153501207_153502250 | 8.39 |
Ubqln2 |
ubiquilin 2 |
3501 |
0.22 |
chr4_55928799_55929534 | 8.34 |
Gm12519 |
predicted gene 12519 |
64573 |
0.14 |
chr13_28881136_28881895 | 8.32 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
1941 |
0.32 |
chr6_143259703_143261097 | 8.24 |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
14507 |
0.2 |
chr18_43686487_43688415 | 8.18 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr10_29143400_29144848 | 8.10 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr1_14303973_14305599 | 7.89 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
158 |
0.97 |
chr13_53469049_53469604 | 7.69 |
Msx2 |
msh homeobox 2 |
3748 |
0.23 |
chr1_81077232_81078427 | 7.46 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr1_163308490_163310681 | 7.45 |
Gm37644 |
predicted gene, 37644 |
518 |
0.77 |
chr1_78186833_78187893 | 7.32 |
Pax3 |
paired box 3 |
9475 |
0.23 |
chr6_144202688_144204608 | 7.30 |
Sox5 |
SRY (sex determining region Y)-box 5 |
409 |
0.92 |
chr14_76420544_76421824 | 7.25 |
Tsc22d1 |
TSC22 domain family, member 1 |
2356 |
0.39 |
chr12_29534253_29535510 | 7.14 |
Gm20208 |
predicted gene, 20208 |
10 |
0.8 |
chr15_50883181_50884101 | 7.10 |
Trps1 |
transcriptional repressor GATA binding 1 |
835 |
0.64 |
chr2_32428080_32429746 | 7.02 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr15_92598307_92599654 | 7.01 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr3_86543379_86544222 | 7.01 |
Lrba |
LPS-responsive beige-like anchor |
1767 |
0.38 |
chr8_45507516_45508498 | 7.01 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr6_15188050_15189424 | 6.91 |
Foxp2 |
forkhead box P2 |
3174 |
0.4 |
chr14_75963198_75963625 | 6.87 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
8402 |
0.18 |
chr3_5224377_5225076 | 6.86 |
Zfhx4 |
zinc finger homeodomain 4 |
3221 |
0.24 |
chr18_22345719_22346098 | 6.77 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
819 |
0.78 |
chr3_134330789_134331989 | 6.76 |
Gm43558 |
predicted gene 43558 |
25903 |
0.15 |
chr18_23036665_23037864 | 6.75 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr2_94484217_94484568 | 6.75 |
Api5 |
apoptosis inhibitor 5 |
46256 |
0.12 |
chr8_107547828_107548491 | 6.72 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
2736 |
0.24 |
chr9_61376232_61377980 | 6.71 |
Tle3 |
transducin-like enhancer of split 3 |
1577 |
0.38 |
chr14_98164357_98165375 | 6.68 |
Dach1 |
dachshund family transcription factor 1 |
4677 |
0.28 |
chr1_173389412_173390669 | 6.65 |
Cadm3 |
cell adhesion molecule 3 |
22345 |
0.14 |
chr8_14381737_14382325 | 6.63 |
Dlgap2 |
DLG associated protein 2 |
35 |
0.98 |
chr10_96955848_96956583 | 6.63 |
Gm33981 |
predicted gene, 33981 |
2656 |
0.34 |
chr18_59062200_59063436 | 6.62 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr6_23382210_23383537 | 6.52 |
Cadps2 |
Ca2+-dependent activator protein for secretion 2 |
26954 |
0.22 |
chr7_130259899_130260467 | 6.42 |
Fgfr2 |
fibroblast growth factor receptor 2 |
1674 |
0.49 |
chr7_36710059_36710756 | 6.40 |
Gm37452 |
predicted gene, 37452 |
233 |
0.9 |
chr8_108716860_108718878 | 6.37 |
Zfhx3 |
zinc finger homeobox 3 |
3225 |
0.3 |
chr1_78195176_78196209 | 6.31 |
Pax3 |
paired box 3 |
1146 |
0.55 |
chr3_34652462_34653573 | 6.30 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr8_33833218_33834143 | 6.30 |
Rbpms |
RNA binding protein gene with multiple splicing |
9991 |
0.16 |
chr12_36315313_36316308 | 6.29 |
Sostdc1 |
sclerostin domain containing 1 |
1671 |
0.31 |
chr8_22012864_22013642 | 6.28 |
Ccdc70 |
coiled-coil domain containing 70 |
42657 |
0.08 |
chr3_34653590_34654523 | 6.25 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chr3_38892303_38893788 | 6.24 |
Fat4 |
FAT atypical cadherin 4 |
2103 |
0.36 |
chr3_5236403_5236857 | 6.23 |
Zfhx4 |
zinc finger homeodomain 4 |
5042 |
0.22 |
chr1_172483328_172483617 | 6.16 |
Igsf9 |
immunoglobulin superfamily, member 9 |
1158 |
0.32 |
chr13_73117045_73117937 | 6.15 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
115904 |
0.06 |
chr18_69349496_69350227 | 6.04 |
Tcf4 |
transcription factor 4 |
917 |
0.69 |
chr3_45384939_45386122 | 6.04 |
Pcdh10 |
protocadherin 10 |
2897 |
0.22 |
chr1_42711455_42712692 | 6.01 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
1381 |
0.34 |
chr2_6881042_6881689 | 5.99 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr4_107436534_107437723 | 5.96 |
Glis1 |
GLIS family zinc finger 1 |
1870 |
0.28 |
chrX_58033180_58034063 | 5.96 |
Zic3 |
zinc finger protein of the cerebellum 3 |
2611 |
0.36 |
chr2_136058799_136059736 | 5.95 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
164 |
0.96 |
chr9_41587250_41587725 | 5.85 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
282 |
0.84 |
chr12_49387532_49388566 | 5.85 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr11_69834618_69835201 | 5.84 |
Nlgn2 |
neuroligin 2 |
60 |
0.9 |
chr1_42259362_42260538 | 5.84 |
Gm28175 |
predicted gene 28175 |
1905 |
0.34 |
chr12_33960516_33961726 | 5.81 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
3450 |
0.27 |
chr4_48586297_48586448 | 5.80 |
Tmeff1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
821 |
0.65 |
chr3_144223529_144223825 | 5.80 |
Lmo4 |
LIM domain only 4 |
18457 |
0.18 |
chr8_12398370_12398923 | 5.79 |
Gm25239 |
predicted gene, 25239 |
2243 |
0.21 |
chr7_128690432_128691249 | 5.79 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr1_137902800_137903236 | 5.76 |
Gm4258 |
predicted gene 4258 |
4420 |
0.1 |
chr4_116223265_116224130 | 5.76 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr1_136228373_136230942 | 5.76 |
Inava |
innate immunity activator |
362 |
0.76 |
chr17_90452868_90453681 | 5.75 |
Nrxn1 |
neurexin I |
1548 |
0.36 |
chr19_38348426_38349048 | 5.75 |
Gm50150 |
predicted gene, 50150 |
6123 |
0.16 |
chr2_71749562_71750513 | 5.72 |
Gm13662 |
predicted gene 13662 |
112 |
0.93 |
chr16_78313182_78314564 | 5.68 |
Cxadr |
coxsackie virus and adenovirus receptor |
11334 |
0.15 |
chr1_69591491_69592135 | 5.67 |
Gm29112 |
predicted gene 29112 |
6709 |
0.24 |
chr3_149705320_149706167 | 5.66 |
Gm31121 |
predicted gene, 31121 |
45347 |
0.2 |
chr6_101198088_101199306 | 5.64 |
Gm26911 |
predicted gene, 26911 |
39 |
0.89 |
chr3_50443042_50444382 | 5.64 |
Slc7a11 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
98 |
0.98 |
chr1_138840496_138840948 | 5.60 |
Lhx9 |
LIM homeobox protein 9 |
1707 |
0.3 |
chr10_103025069_103025608 | 5.58 |
Alx1 |
ALX homeobox 1 |
1123 |
0.51 |
chr16_7149214_7150856 | 5.56 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
43712 |
0.22 |
chr18_81165961_81166641 | 5.51 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chr2_72426765_72427714 | 5.48 |
Cdca7 |
cell division cycle associated 7 |
48920 |
0.13 |
chr2_80126598_80127760 | 5.48 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
1655 |
0.42 |
chr19_55749292_55750940 | 5.48 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
7271 |
0.3 |
chr3_45382505_45382699 | 5.48 |
Pcdh10 |
protocadherin 10 |
31 |
0.97 |
chr17_90088736_90088977 | 5.48 |
Nrxn1 |
neurexin I |
456 |
0.9 |
chrX_88114828_88115362 | 5.48 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
550 |
0.84 |
chrX_147552057_147552289 | 5.47 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1877 |
0.42 |
chr2_116056837_116059755 | 5.45 |
Meis2 |
Meis homeobox 2 |
546 |
0.75 |
chr7_79501250_79502506 | 5.45 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr3_55782023_55782190 | 5.44 |
Mab21l1 |
mab-21-like 1 |
404 |
0.8 |
chr3_149074725_149075712 | 5.43 |
Gm25127 |
predicted gene, 25127 |
46286 |
0.14 |
chr12_91683421_91686419 | 5.41 |
Gm16876 |
predicted gene, 16876 |
255 |
0.86 |
chr6_94715175_94715399 | 5.36 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
15129 |
0.21 |
chr2_65620767_65621991 | 5.35 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr4_82915737_82916950 | 5.35 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
1909 |
0.38 |
chr17_17402413_17403374 | 5.34 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr15_35300127_35300802 | 5.34 |
Osr2 |
odd-skipped related 2 |
164 |
0.96 |
chr17_85394123_85395241 | 5.33 |
Rpl31-ps16 |
ribosomal protein L31, pseudogene 16 |
103951 |
0.07 |
chr3_158559356_158560580 | 5.30 |
Lrrc7 |
leucine rich repeat containing 7 |
1368 |
0.57 |
chr3_38894285_38895428 | 5.30 |
Fat4 |
FAT atypical cadherin 4 |
3914 |
0.27 |
chr6_65674892_65675628 | 5.30 |
Ndnf |
neuron-derived neurotrophic factor |
3670 |
0.28 |
chr2_113828248_113829427 | 5.29 |
Scg5 |
secretogranin V |
75 |
0.97 |
chrX_133684830_133685971 | 5.28 |
Pcdh19 |
protocadherin 19 |
409 |
0.91 |
chr4_110285249_110285423 | 5.28 |
Elavl4 |
ELAV like RNA binding protein 4 |
1280 |
0.61 |
chr2_116052028_116053362 | 5.25 |
Meis2 |
Meis homeobox 2 |
3015 |
0.24 |
chr7_29071185_29072068 | 5.24 |
Gm26604 |
predicted gene, 26604 |
11 |
0.87 |
chr7_137306984_137307575 | 5.23 |
Ebf3 |
early B cell factor 3 |
6637 |
0.2 |
chr6_55678280_55679200 | 5.23 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr13_20472048_20472724 | 5.23 |
Elmo1 |
engulfment and cell motility 1 |
340 |
0.8 |
chr3_5225104_5225624 | 5.20 |
Zfhx4 |
zinc finger homeodomain 4 |
3859 |
0.22 |
chr16_43504464_43505047 | 5.19 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr9_52148115_52149635 | 5.19 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr14_118362932_118364036 | 5.18 |
Gm26791 |
predicted gene, 26791 |
248 |
0.89 |
chr6_93543493_93544179 | 5.18 |
Gm22312 |
predicted gene, 22312 |
34263 |
0.2 |
chr1_89848531_89848837 | 5.17 |
Gm37521 |
predicted gene, 37521 |
23203 |
0.19 |
chr18_69500231_69501482 | 5.13 |
Tcf4 |
transcription factor 4 |
20 |
0.99 |
chr15_73021529_73022598 | 5.12 |
Trappc9 |
trafficking protein particle complex 9 |
33747 |
0.18 |
chr5_37825667_37826469 | 5.11 |
Msx1 |
msh homeobox 1 |
1485 |
0.42 |
chr4_103619552_103620735 | 5.09 |
Dab1 |
disabled 1 |
478 |
0.8 |
chr1_138876073_138877030 | 5.07 |
1700019P21Rik |
RIKEN cDNA 1700019P21 gene |
400 |
0.75 |
chr13_44946654_44947258 | 5.05 |
Dtnbp1 |
dystrobrevin binding protein 1 |
188 |
0.96 |
chr9_71894609_71895239 | 5.05 |
Tcf12 |
transcription factor 12 |
1061 |
0.37 |
chr10_68355791_68356390 | 5.05 |
4930545H06Rik |
RIKEN cDNA 4930545H06 gene |
34948 |
0.17 |
chr3_66746318_66747483 | 5.03 |
Gm6555 |
predicted gene 6555 |
135450 |
0.05 |
chr7_109174148_109175577 | 5.03 |
Lmo1 |
LIM domain only 1 |
345 |
0.88 |
chr13_83732205_83734272 | 5.01 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr3_99261050_99262399 | 5.01 |
Gm43120 |
predicted gene 43120 |
439 |
0.81 |
chr8_96455054_96456367 | 5.00 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chr12_41483283_41485192 | 4.99 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr8_26677322_26677990 | 4.98 |
Gm32098 |
predicted gene, 32098 |
9350 |
0.18 |
chr1_19213854_19215338 | 4.96 |
Tfap2b |
transcription factor AP-2 beta |
717 |
0.69 |
chr1_163358681_163359585 | 4.95 |
Gm24940 |
predicted gene, 24940 |
43150 |
0.12 |
chr11_36676450_36677161 | 4.95 |
Tenm2 |
teneurin transmembrane protein 2 |
940 |
0.7 |
chr3_67892808_67893503 | 4.93 |
Iqschfp |
Iqcj and Schip1 fusion protein |
923 |
0.42 |
chr2_105675959_105678109 | 4.92 |
Pax6 |
paired box 6 |
905 |
0.54 |
chr8_45508499_45509041 | 4.90 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
852 |
0.61 |
chr19_59462586_59463447 | 4.89 |
Emx2 |
empty spiracles homeobox 2 |
214 |
0.92 |
chr5_48598987_48600332 | 4.86 |
Kcnip4 |
Kv channel interacting protein 4 |
23 |
0.97 |
chr13_55962186_55963636 | 4.86 |
Gm47071 |
predicted gene, 47071 |
39354 |
0.14 |
chr15_50884152_50885280 | 4.85 |
Trps1 |
transcriptional repressor GATA binding 1 |
1910 |
0.34 |
chr1_42686011_42687379 | 4.84 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr6_125803223_125804196 | 4.83 |
Ano2 |
anoctamin 2 |
11825 |
0.23 |
chr13_83715222_83716973 | 4.82 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr18_69607928_69608487 | 4.80 |
Tcf4 |
transcription factor 4 |
4237 |
0.32 |
chr5_116312100_116312726 | 4.79 |
B230112J18Rik |
RIKEN cDNA B230112J18 gene |
53 |
0.96 |
chr7_64855942_64856628 | 4.79 |
Fam189a1 |
family with sequence similarity 189, member A1 |
112 |
0.97 |
chr18_72348735_72348916 | 4.77 |
Dcc |
deleted in colorectal carcinoma |
2192 |
0.45 |
chr9_91378153_91379783 | 4.76 |
Zic4 |
zinc finger protein of the cerebellum 4 |
326 |
0.81 |
chr4_54950838_54951442 | 4.76 |
Zfp462 |
zinc finger protein 462 |
3164 |
0.35 |
chr10_57784547_57786586 | 4.76 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr15_50885475_50885991 | 4.75 |
Trps1 |
transcriptional repressor GATA binding 1 |
2927 |
0.26 |
chr14_29718651_29719941 | 4.73 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
2499 |
0.26 |
chr18_37217058_37218378 | 4.73 |
Gm10544 |
predicted gene 10544 |
39196 |
0.08 |
chr5_98182267_98183697 | 4.73 |
Prdm8 |
PR domain containing 8 |
2004 |
0.26 |
chr10_73821409_73822534 | 4.73 |
Pcdh15 |
protocadherin 15 |
28 |
0.99 |
chr10_103029624_103030791 | 4.72 |
Alx1 |
ALX homeobox 1 |
8 |
0.64 |
chr13_99443316_99444666 | 4.72 |
Map1b |
microtubule-associated protein 1B |
47 |
0.98 |
chr3_55778948_55779699 | 4.71 |
Mab21l1 |
mab-21-like 1 |
3187 |
0.25 |
chr2_52860105_52860808 | 4.70 |
Fmnl2 |
formin-like 2 |
2588 |
0.39 |
chr2_45158033_45158832 | 4.69 |
Gm28643 |
predicted gene 28643 |
1507 |
0.46 |
chr19_59461902_59462365 | 4.69 |
Emx2 |
empty spiracles homeobox 2 |
669 |
0.65 |
chr5_13127003_13127271 | 4.68 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
1544 |
0.35 |
chr3_5222045_5223052 | 4.64 |
Zfhx4 |
zinc finger homeodomain 4 |
1043 |
0.46 |
chr18_83332439_83332789 | 4.62 |
4921531P14Rik |
RIKEN cDNA 4921531P14 gene |
6730 |
0.16 |
chr10_115493546_115494319 | 4.61 |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
30853 |
0.16 |
chr3_86544323_86545126 | 4.60 |
Lrba |
LPS-responsive beige-like anchor |
2031 |
0.33 |
chr4_97585271_97585742 | 4.58 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
870 |
0.67 |
chrX_166344665_166345995 | 4.58 |
Gpm6b |
glycoprotein m6b |
488 |
0.85 |
chr5_37818003_37820431 | 4.57 |
Msx1 |
msh homeobox 1 |
5365 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 22.3 | GO:0060594 | mammary gland specification(GO:0060594) |
5.6 | 16.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
5.5 | 16.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.8 | 14.3 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
4.5 | 31.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
4.5 | 17.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
4.0 | 12.0 | GO:0048880 | sensory system development(GO:0048880) |
3.7 | 7.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
3.7 | 11.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
3.6 | 3.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
3.4 | 16.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
3.4 | 10.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.4 | 6.7 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
3.3 | 19.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.2 | 9.7 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
3.2 | 9.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
3.0 | 17.7 | GO:0072017 | distal tubule development(GO:0072017) |
2.9 | 20.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.8 | 8.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.7 | 21.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.6 | 12.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.5 | 27.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.5 | 17.3 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
2.4 | 2.4 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
2.4 | 14.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.4 | 16.7 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.3 | 4.5 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.2 | 8.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
2.1 | 6.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.1 | 6.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.1 | 2.1 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
2.1 | 8.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.0 | 4.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
2.0 | 7.9 | GO:0060023 | soft palate development(GO:0060023) |
1.9 | 3.9 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
1.9 | 15.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.9 | 3.9 | GO:0060166 | olfactory pit development(GO:0060166) |
1.9 | 3.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.9 | 7.5 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
1.9 | 13.1 | GO:0097264 | self proteolysis(GO:0097264) |
1.8 | 5.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.8 | 5.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.8 | 5.3 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.8 | 1.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.7 | 1.7 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.7 | 5.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.7 | 3.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.7 | 6.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.6 | 3.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.6 | 6.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.6 | 1.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.6 | 3.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.6 | 1.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.5 | 6.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
1.5 | 3.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.5 | 2.9 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.5 | 4.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.4 | 4.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.4 | 14.2 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 2.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.4 | 1.4 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.4 | 17.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.4 | 2.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.4 | 2.7 | GO:0061205 | paramesonephric duct development(GO:0061205) |
1.4 | 5.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.3 | 6.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.3 | 2.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.3 | 4.0 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.3 | 4.0 | GO:0008038 | neuron recognition(GO:0008038) |
1.3 | 5.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.3 | 8.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.3 | 5.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.3 | 1.3 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.3 | 3.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.3 | 6.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.3 | 6.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.2 | 4.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.2 | 3.6 | GO:0060513 | prostatic bud formation(GO:0060513) |
1.1 | 1.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
1.1 | 2.3 | GO:0060174 | limb bud formation(GO:0060174) |
1.1 | 4.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.1 | 3.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.1 | 10.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.1 | 3.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.1 | 3.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.1 | 5.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.0 | 1.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.0 | 3.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.0 | 16.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.0 | 1.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.0 | 10.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.0 | 1.0 | GO:0010159 | specification of organ position(GO:0010159) |
1.0 | 3.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.0 | 4.0 | GO:0030035 | microspike assembly(GO:0030035) |
1.0 | 2.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 3.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.0 | 3.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.0 | 6.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.0 | 3.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.0 | 2.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.0 | 1.0 | GO:0070384 | Harderian gland development(GO:0070384) |
1.0 | 2.9 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.0 | 1.9 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
1.0 | 22.0 | GO:0001964 | startle response(GO:0001964) |
1.0 | 10.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.0 | 5.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.9 | 2.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.9 | 1.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 4.7 | GO:0035989 | tendon development(GO:0035989) |
0.9 | 0.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.9 | 9.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.9 | 3.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.9 | 11.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 43.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 0.9 | GO:0090427 | activation of meiosis(GO:0090427) |
0.9 | 2.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.9 | 2.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 3.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.9 | 5.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.9 | 69.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.9 | 5.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 3.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 0.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.8 | 0.8 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.8 | 2.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.8 | 0.8 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.8 | 2.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 12.5 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.8 | 1.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 1.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.8 | 4.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 4.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 2.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.8 | 0.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.8 | 2.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.8 | 2.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.8 | 1.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.8 | 2.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 2.3 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.8 | 1.6 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.8 | 1.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.8 | 2.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.8 | 3.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.8 | 3.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.8 | 1.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.7 | 3.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.7 | 1.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.7 | 0.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.7 | 1.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.7 | 2.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.7 | 2.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.7 | 1.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 10.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 11.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.7 | 2.1 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.7 | 1.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.7 | 2.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 4.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.7 | 2.8 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 2.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 2.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.7 | 15.8 | GO:0021766 | hippocampus development(GO:0021766) |
0.7 | 0.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.7 | 2.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.7 | 1.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.7 | 4.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.7 | 3.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.7 | 10.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.7 | 2.0 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.7 | 11.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 2.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 0.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.6 | 1.3 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.6 | 2.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 1.3 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.6 | 1.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 13.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.6 | 5.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.6 | 0.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.6 | 8.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 2.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 1.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 2.4 | GO:0033504 | floor plate development(GO:0033504) |
0.6 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.6 | 1.8 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.6 | 0.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.6 | 6.0 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.6 | 0.6 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.6 | 3.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.6 | 1.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.6 | 1.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.6 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 3.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 1.7 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.6 | 1.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.6 | 2.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.6 | 7.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.6 | 17.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.5 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.5 | 1.6 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.5 | 1.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 0.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.5 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 2.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 3.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 1.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 0.5 | GO:0044849 | estrous cycle(GO:0044849) |
0.5 | 1.5 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 1.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.5 | 1.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 4.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 8.9 | GO:0007616 | long-term memory(GO:0007616) |
0.5 | 1.5 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.5 | 1.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 2.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 1.0 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.5 | 1.4 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.5 | 1.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.5 | 0.5 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.5 | 0.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 0.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.5 | 1.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.5 | 0.9 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.5 | 34.5 | GO:0007411 | axon guidance(GO:0007411) |
0.5 | 1.9 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 0.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.4 | 1.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 3.9 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.4 | 1.3 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.4 | 1.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 0.9 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 2.2 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.4 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 0.9 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 3.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.4 | 3.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 1.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 2.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.4 | 4.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.4 | 1.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 0.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.4 | 3.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 4.1 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 1.2 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.4 | 0.4 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.4 | 1.6 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.4 | 0.8 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 1.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 0.4 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.4 | 3.2 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.4 | 2.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 1.2 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.4 | 1.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 2.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.4 | 1.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.4 | 0.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 2.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 1.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 0.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.4 | 2.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 2.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.4 | 1.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 1.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 1.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 2.3 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.4 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 0.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 2.9 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.4 | 1.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 0.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.4 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 3.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 0.7 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.3 | 0.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 2.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 0.3 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.3 | 2.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 1.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 0.7 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 1.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.3 | 1.4 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 0.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 0.7 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.3 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 3.7 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.3 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 1.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 1.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 1.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 9.7 | GO:0060612 | adipose tissue development(GO:0060612) |
0.3 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.3 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.3 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.3 | 5.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 0.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 0.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 1.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 1.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 2.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 0.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 1.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 0.3 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 1.5 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.3 | 0.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 2.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 2.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.3 | 0.9 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.5 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.3 | 1.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.3 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.6 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.3 | 0.9 | GO:0060438 | trachea development(GO:0060438) |
0.3 | 0.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.3 | 0.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 1.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 0.9 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.3 | 0.8 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 0.8 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 0.3 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 0.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 0.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 3.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 0.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 4.4 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.3 | 0.5 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 1.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 1.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 7.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 0.3 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.3 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 0.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 4.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.3 | 7.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 7.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.8 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 0.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.7 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 2.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 3.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.2 | 2.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 3.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.5 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 2.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 1.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.5 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.5 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.2 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 2.4 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 1.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.2 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.2 | 0.2 | GO:0072243 | metanephric nephron epithelium development(GO:0072243) |
0.2 | 2.6 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.2 | GO:0035787 | cell migration involved in kidney development(GO:0035787) |
0.2 | 10.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 1.9 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 2.1 | GO:0060004 | reflex(GO:0060004) |
0.2 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.6 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.2 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 4.2 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 1.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 0.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.2 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.2 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.2 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 1.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 1.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 1.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.2 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.7 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.2 | 0.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.5 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.2 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 2.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.2 | 2.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.2 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 1.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 1.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.5 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 0.8 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 1.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.8 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.2 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 1.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.2 | 1.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.8 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.5 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 5.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.2 | 0.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 2.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 1.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 2.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.7 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 1.6 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 4.4 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 2.0 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 0.1 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.6 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 1.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.6 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 1.3 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.8 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.4 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.5 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.4 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 2.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.4 | GO:0021761 | limbic system development(GO:0021761) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 1.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.2 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 1.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.8 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 2.1 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.1 | 1.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.1 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 1.4 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 1.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.5 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 1.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 1.1 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.2 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 0.7 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.1 | 0.2 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.4 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.5 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 3.6 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 1.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.7 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.2 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.5 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.4 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 1.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.1 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 9.0 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.1 | 0.1 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 1.8 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.1 | 1.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.7 | GO:0051905 | establishment of melanosome localization(GO:0032401) establishment of pigment granule localization(GO:0051905) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.3 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.1 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 2.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.6 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 1.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 1.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.2 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.1 | 0.5 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.1 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 1.0 | GO:0050905 | neuromuscular process(GO:0050905) |
0.1 | 0.5 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.5 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 1.6 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.1 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.2 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.1 | 0.3 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 1.5 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.2 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.1 | 1.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 3.4 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.2 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.0 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.0 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.5 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.2 | GO:0060173 | appendage development(GO:0048736) limb development(GO:0060173) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0048799 | organ maturation(GO:0048799) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.0 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.0 | 0.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 0.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.0 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 1.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.0 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:2000343 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 0.0 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) ketone body metabolic process(GO:1902224) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.8 | 18.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.8 | 5.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.6 | 13.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.5 | 1.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.3 | 9.4 | GO:0032584 | growth cone membrane(GO:0032584) |
1.3 | 15.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.2 | 4.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.1 | 4.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.1 | 6.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.1 | 10.6 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 3.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.9 | 7.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 24.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.9 | 49.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.9 | 3.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 2.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 7.1 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 2.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.7 | 11.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 0.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 2.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.7 | 10.1 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 2.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 2.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.7 | 7.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 2.6 | GO:0097433 | dense body(GO:0097433) |
0.6 | 5.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.6 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 2.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 96.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 5.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 1.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 4.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.5 | 1.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 3.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 4.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 4.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 1.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 5.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.5 | 2.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 1.0 | GO:0044393 | microspike(GO:0044393) |
0.5 | 1.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.5 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.4 | 0.9 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 0.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 6.1 | GO:0043205 | fibril(GO:0043205) |
0.4 | 2.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 2.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 4.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 2.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 10.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 3.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 32.6 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 30.0 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 6.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 0.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 8.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 17.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 0.7 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 1.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.3 | 2.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 1.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 3.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 98.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 6.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 0.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 0.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 2.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 1.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 2.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 2.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 2.4 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.6 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 0.6 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 1.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 2.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 25.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 5.6 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 2.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.4 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 4.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.9 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 1.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 34.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 3.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 1.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 6.2 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 1.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.1 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 3.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.7 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 2.7 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 4.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 15.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 1.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.2 | GO:0044304 | main axon(GO:0044304) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.0 | 3.4 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 2.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 2.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 18.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.4 | 13.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.6 | 17.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.4 | 23.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
3.0 | 26.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.7 | 10.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.5 | 5.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.3 | 13.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.2 | 15.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.1 | 19.0 | GO:0038191 | neuropilin binding(GO:0038191) |
2.0 | 10.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.7 | 8.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.6 | 4.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.4 | 4.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 16.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.4 | 2.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.3 | 4.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.3 | 7.9 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 6.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.3 | 3.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.2 | 4.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.2 | 13.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.1 | 5.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.1 | 4.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 3.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 3.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 3.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.0 | 2.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.0 | 3.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.0 | 3.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.0 | 3.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.0 | 16.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 19.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.9 | 9.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 6.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 2.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.8 | 5.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.8 | 7.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.8 | 2.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 3.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.8 | 3.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 5.3 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 3.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.7 | 3.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 9.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 8.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 2.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.7 | 2.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 1.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 16.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.6 | 1.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 1.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 1.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.6 | 4.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 1.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.6 | 14.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 2.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.6 | 8.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.6 | 12.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.6 | 0.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.6 | 1.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 2.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 3.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 1.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.5 | 1.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 4.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.5 | 3.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 4.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 0.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.5 | 4.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 4.1 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 5.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 3.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 14.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.5 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 2.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 5.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 1.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 1.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 1.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 11.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 8.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 0.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 2.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.5 | 4.6 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.5 | 4.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 4.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.5 | 5.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 7.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.5 | 5.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.4 | 17.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 1.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.4 | 2.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.4 | 1.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 2.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 2.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 2.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 1.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 2.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 4.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 14.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 0.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 3.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 5.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.4 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 2.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 0.4 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 2.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 4.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 5.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 9.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 1.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 5.6 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 2.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 3.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 1.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 3.2 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 3.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 4.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 2.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 2.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 2.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 7.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 4.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 0.6 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 6.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 3.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 0.3 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.3 | 5.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 6.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 5.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 3.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 1.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.8 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 1.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 2.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.9 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 2.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 2.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 2.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 8.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.7 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 6.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.9 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 1.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 1.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 1.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 1.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 171.9 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 1.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 7.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 2.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 4.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 2.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 1.7 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 1.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 3.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 2.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 2.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.1 | GO:0034562 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 3.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 1.5 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 12.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.9 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0047074 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 5.7 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.8 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 2.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 3.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 2.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.9 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.9 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 8.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.8 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 3.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 46.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 8.2 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 2.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 1.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 0.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 2.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 13.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 1.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.1 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 19.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 22.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 55.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.7 | 21.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.6 | 17.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 11.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 13.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 11.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 6.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 19.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 6.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 4.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 4.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 4.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 3.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 3.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 8.8 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 1.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 10.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 7.2 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 5.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 8.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 27.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 2.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 3.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 14.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 13.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 2.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
1.8 | 47.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.7 | 23.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.3 | 24.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.1 | 14.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.1 | 17.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.8 | 9.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 9.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.8 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.7 | 12.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.7 | 0.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.6 | 8.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 6.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 16.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 2.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.5 | 11.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 11.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 1.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 1.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 8.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 22.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 8.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 1.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 8.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 4.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 3.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 1.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 7.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 5.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 3.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 2.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 3.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 3.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 22.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 1.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 5.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 3.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 3.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 1.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 9.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 3.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 0.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 6.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.2 | 2.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 3.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 6.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.7 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.7 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 2.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 12.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 1.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.1 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 1.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |